ⓘ Plozalizumab

                                     

ⓘ Plozalizumab

Plozalizumab is a humanized monoclonal antibody designed for the treatment of diabetic nephropathy and arteriovenous graft patency.

This drug developed by Takeda international cooperation.

                                     
  • human TNF pain and inflammatory diseases Prezalumab mab human human TNF Plozalizumab mab humanized CCR2 diabetic nephropathy and arteriovenous graft patency